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Abstract 
Introduction: Pressure ulcer-related pelvic osteomyelitis is a relatively under-studied entity in the field 
of bone infection. We sought to add to the limited evidence base for managing this challenging syndrome. 
Methods: Cases were identified retrospectively from a surgical database and hospital discharge codes at 
a U.K. tertiary centre (2009-2018). Risk factors associated with outcomes were analysed by logistic 
regression.  
Results: We identified 35 patients (mean age 57.4 years), 69% managed with a combined medical and 
surgical approach, with mean follow-up of 3.7 years from index admission. Treatment failure (requiring 
further surgery or intravenous antimicrobials) occurred in 71% and eventual ulcer healing in 36%. 
One-year mortality was 23%. Lack of formal care support on discharge, post-traumatic (asensate) 
neurological deficit and index CRP (>184mg/L) were associated with treatment failure (p=0.001). Age 
(>59.5 years), lack of attempted soft tissue coverage, haemoglobin (<111g/L) and albumin (<25g/L) were 
associated with non-healing ulcers (p=0.003). Superficial wound swabs had low sensitivity and specificity 
compared to deep bone microbiology. Infection (based on deep bone microbiology from 46 infection 
episodes) was usually polymicrobial (87%), commonly involving S. aureus, Enterococci, GNB and 
anaerobes. Antimicrobial duration ranged from 0–103 days (mean 54) and was not associated with 
subsequent treatment failure.  
Conclusions: Attempted soft tissue coverage after surgical debridement, ensuring appropriate support 
for personal care after discharge and nutritional optimisation could improve outcomes. Superficial wound 
swabs are uninformative and deep bone sampling should be pursued. Long antimicrobial courses do not 
improve outcomes. Clinicians should engage patients in anticipatory care planning. 
Key words: osteomyelitis, pressure ulcer, pelvis, spinal cord injuries 
Introduction 
Pelvic osteomyelitis occurring as a complication 
of pressure ulcers results in substantial morbidity and 
therapeutic challenges, but remains a relatively 
under-studied entity in the field of bone infection. 
Such pressure ulcers arise due to immobility, usually 
in the context of neurological dysfunction [1]. 
Concomitant urinary incontinence can lead to skin 
irritation further compromising barrier function, and 
faecal incontinence can lead to wound soiling and 
introduction of enteric bacteria. Bone sequestra and 
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necrotic connective tissue, devoid of a blood supply, 
provide a persistent nidus of infection and impair 
local antimicrobial penetration following systemic 
administration. Wound closure and healing following 
surgical intervention are at high risk of failure [2]. 
A recent systematic review of this challenging 
syndrome provides an overview of the limited 
available data pertaining to diagnosis and 
management [3]. Diagnosis itself can be difficult, and 
contrary to the widely held belief, exposed bone is not 
necessarily synonymous with histological evidence of 
osteomyelitis [3]. Furthermore, the specificity of CT 
and MRI has been questioned when histology is 
considered the gold standard [4-9]. The optimum 
duration of antimicrobial therapy has not been 
defined, nor the sub-group of patients who will derive 
benefit from surgical intervention.  
Utilising a single centre cohort of patients we 
sought to add to the limited evidence base for this 
challenging syndrome. We aimed to ask 
clinically-relevant questions including what factors 
are associated with treatment failure and failure of 
ulcer healing, how do deep and superficial 
microbiological samples compare, and whether 
antimicrobial duration is associated with outcome? 
Methods 
Data collection 
Patients from a U.K. tertiary centre were 
identified from a local database of patients 
undergoing surgical management of osteomyelitis, 
supplemented by an electronic search of the electronic 
patient record (TrakCare®) for episodes with 
diagnoses coded (Table S1) as osteomyelitis of the 
pelvis, sacrum, coccyx or ischium, or infected 
pressure ulcers (December 2009-December 2018). 
Cases identified by the latter search were then 
reviewed to determine if they met the case definition 
(below). The case log was created following a search 
of the pan-regional electronic perioperative manage-
ment system (Operating Room Scheduling and Office 
System), reflecting an entire regional surgical practice. 
TrakCare® is a region-wide electronic medical record 
system. It collects the medical data from patient 
interactions in all secondary and tertiary centres 
throughout the region. Death is recorded on Trak-
Care® and linked to national death records by the 
patient's community health index number, a unique 
patient identifier assigned to all users of the health-
care system in Scotland. Chart review was undertaken 
and relevant clinical, radiological and microbiological 
details were recorded. The project was reviewed and 
approved by the NHS Lothian Musculoskeletal- 
Orthopaedic Quality Improvement Team. 
Definitions 
Cases were defined as adults (≥18 years) 
requiring inpatient management of clinically and 
radiologically diagnosed pressure ulcer-related pelvic 
osteomyelitis. Patients were excluded if they 
presented with soft tissue infection involving an ulcer 
or visible bone (i.e. grade 4 ulcer) without evidence of 
underlying osteomyelitis. The index episode was 
defined as the initial presentation requiring inpatient 
management including the first surgical procedure. 
Treatment failure was defined as: (i) further surgical 
debridement, (ii) further positive bone cultures, or (iii) 
re-admission for intravenous antimicrobials for 
treatment of pelvic osteomyelitis. This expands on a 
recently used definition with the addition of 
requirement for further antimicrobials, which we 
contend is a relevant outcome for patients [10]. 
Patients requiring surgical debridement underwent 
wide resection with dissection down to bleeding 
bone. Bone prominences were removed to prevent 
future skin pressure. Where possible, defects were 
closed primarily or covered with a flap 
reconstruction. If neither option was possible in the 
first instance, negative pressure wound dressings 
were applied to facilitate delayed closure +/- soft 
tissue reconstruction. Multiple intraoperative deep 
bone samples were taken for microbiological 
investigation (usually six) and at least one sample for 
histological analysis (soft tissue +/- bone). 
Significant microbiology 
Isolates of uncertain clinical significance in the 
context of osteomyelitis (e.g. Corynebacterium spp., 
coagulase-negative Staphylococci [excluding S. 
lugdunensis], viridans group Streptococci, fungi) were 
considered as significant if they were recovered from 
>1 deep sample from the same procedure and had a 
similar antibiogram, or if they were recovered from 
the same patient during a subsequent infection 
episode. 
Statistical analysis 
Fisher’s exact-test (or a Chi-square test where 
appropriate) was used to analyse the difference 
between groups for categorical variables, and a 
univariate analysis of variance (or Mann Witney U 
test for non-parametric data) for continuous variables. 
A Kaplan Meier survival curve with a log-rank 
analysis was used for comparative evaluations of 
treatment failure and mortality in time. Possible risk 
factors for treatment failure were selected and 
analysed using univariate analysis as detailed above. 
Receiver operator characteristic (ROC) analysis was 
performed to quantitate the predictive performance of 
risk factors identified on univariate analysis, in 
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addition the Youden’s J statistic was calculated for 
identified continuous variables. Identified variables 
on univariate analysis were assessed for multi-
collinearity in a binomial logistic regression analysis 
with only statistically significant variables included in 
the risk score model. All analyses were two-tailed and 
p-values <0.05 were considered to be statistically 
significant. Statistical analysis was performed using 
SPSS, version 24.0 (SPSS Inc. Chicago, IL) and Prism, 
version 8.0 (GraphPad Software Inc. San Diego, CA). 
Results 
Patient characteristics 
Thirty five patients with pressure ulcer-related 
pelvic osteomyelitis were included. The mean age was 
57.4 years (95% CI 52.1–62.8) and 26/35 (74%) were 
male. Most patients (32/35) had neurological dys-
function resulting in immobility, with frailty (2/35) 
and rheumatoid arthritis (1/35) as predisposing 
factors in the remaining cases. Other co-morbidities 
were uncommon (median 0, range 1–3; Table 1). The 
most common site of osteomyelitis was the ischium 
(18/35). Full patient characteristics are reported in 
Table 1. 31/35 index admissions were directly due to 
pelvic osteomyelitis (due to other intercurrent 
infections in the remaining 4) and in 27 such instances 
the patient was acutely unwell due to osteomyelitis 
and/or skin and soft tissue infection (SSTI) involving 
the ulcer (admitted electively for surgery in remaining 
4). The responsible pressure ulcers had been present 
for a median of 4 months (IQR 1.75–12.0) and were 
most commonly grade four (21/35) or three (13/35). 
There was one case of squamous cell carcinoma as a 
complication of the infection. 
Diagnostic parameters at index presentation are 
presented in Table 1. Clinical signs of SSTI involving 
the ulcer were present in 29/35 cases. Samples of bone 
were sent to histopathology in nine cases, with active 
inflammation identified in seven. In the two cases 
where only reactive changes were reported, MRI 
identified sequestra and erosions, and bone samples 
from the same operations sent to microbiology were 
culture-positive. 
Management 
The majority of patients were managed with a 
combined medical and surgical approach (24/35). 
One patient underwent flap reconstruction during 
their index presentation followed by one re-admission 
for debridement and flap elevation. Three patients 
underwent flap reconstruction on their second 
re-admission and required no further intervention. Of 
the patients who underwent direct primary closure, 
11/14 experienced wound breakdown with six 
requiring further surgical intervention and five 
requiring further antimicrobials only. They required a 
median of one further admission (range 0–7), with 
7/14 having wounds that had healed at the time of 
chart review. 
The mean total antimicrobial duration during 
the index episode was 54 days (standard deviation 
±31 days), but this was highly variable (Figure 1A), 
with a range of 0–103 days. There was no association 
between antimicrobial duration and subsequent 
treatment failure (51.0 days treatment success, 55.7 
days treatment failure, p=0.7). When patients were 
stratified into receiving ≤6 weeks or >6 weeks of 
antimicrobials there remained no association with 
subsequent treatment failure (p=0.7). Patients 
received a median of 4 antimicrobials in total (IQR 2–
6), with flucloxacillin, vancomycin, metronidazole, 
piperacillin-tazobactam and ciprofloxacin constitu-
ting over half (Figure 1B). Broad spectrum 
beta-lactams (piperacillin-tazobactam, co-amoxiclav, 
meropenem) were used for average durations of 17, 
30 and 19 days respectively (Figure 1C). Despite the 
extensive antimicrobial exposure there was only one 
case of Clostridioides difficile infection. Seven patients 
developed adverse drug reactions involving 
antimicrobials, including nephrotoxicity (vancomycin 
and gentamicin), hyper-sensitivity (teicoplanin and 
co-trimoxazole) and anaemia (linezolid). 
Outcomes 
Follow-up and mortality 
At time of chart review 15/35 (43%) patients had 
died, with 8/35 (23%) dying within twelve months of 
their index episode. Kaplan-Meier analysis provided 
an estimated median time to death from index 
episode of 7.0 years (95% CI 2.7–11.3) for the entire 
cohort (Figure 2A). Median time to death in patients 
with healed pressure ulcers was 7.0 years (95% CI not 
available) and unhealed pressure ulcers was 2.0 years 
(95% CI 0.6–3.4 years; p=0.003, Figure 2B). Excluding 
the 15 deaths, there was a mean follow-up of 3.7 years 
(range 1.3–7.2). 
Ulcer healing 
Unhealed pressure ulcers were present in 21/33 
(64%) patients at the time of chart review or death. 
Univariate analysis identified older age (mean 63.4 vs. 
48.9 years, p=0.010), diagnosis of diabetes mellitus 
(7/21 vs. 0/12, p=0.032), lower haemoglobin and 
albumin at index presentation (mean 105 vs. 125g L-1, 
p=0.007; and 22.1 vs. 27.2g L-1, p=0.040, respectively), 
and not attempting soft tissue coverage at index 
presentation (8/20 vs. 10/12 primary closure as 
opposed to no closure or negative pressure wound 
dressing, p=0.028) to be associated with an unhealed 
ulcer. Receiver operating characteristic (ROC) 
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analysis is presented in Table 2. Binomial logistic 
regression analysis (X2(4) = 15.781, p=0.003) found 
that admission haemoglobin (<111g L-1), admission 
albumin (<25g L-1), lack of soft tissue coverage, and 
patient age at index presentation (>59.5 years) 
accounted for 79.3% (Nagelkerke R2) of the variance in 
the failure of pressure ulcers to heal and correctly 
classified 90.5% of cases (Table S2). 
Treatment failure 
Treatment failure occurred in 25/35 (71.4%) 
cases. The median time from index presentation was 
9.3 months (95% CI 2.7–15.9) (Figure 2C). Univariate 
analysis found that lack of formal care support on 
discharge (relative risk ratio [RRR] 3.2, p=0.027), an 
underlying asensate post-traumatic neurological 
deficit (RRR N/A, p=0.030), and higher index 
admission C-reactive protein (194 vs. 105mg L-1, 
p=0.021) (Figure 2D) were associated with treatment 
failure. Bacteraemia on index admission was not 
associated with subsequent treatment failure (p=1.0). 
Receiver operating characteristic (ROC) analysis is 
presented in Table 2. Binomial logistic regression 
analysis (X2(3) = 15.588, p=0.001) found that index 
CRP (>184mg L-1), lack of formal care support and a 
post-traumatic neurological deficit accounted for 
52.4% (Nagelkerke R2) of the variance in treatment 
failure and correctly classified 82% of cases (Table S2). 
 
 
Figure 1. Antimicrobial usage. a) The total antimicrobial duration at index presentation was not associated with subsequent treatment failure (groups compared by unpaired 
t test). b) Antimicrobial agents used during management of index episode. c) Duration of each antimicrobial agent during index episodes (number is mean). Antimicrobial data 
available for 33 patients. Graphs show mean and standard deviation.  
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Figure 2. Clinical outcomes. a) Kaplan-Meier analysis of patient survival. b) Log rank analysis of patient survival between those with healed and non-healed pressure ulcers 
at time of final follow-up. c) Treatment failure. d) Admission C-reactive protein (mg L-1) at index presentation in the prediction of treatment failure. 
 
Microbiology 
Considering each index admission and any 
subsequent treatment failures as an infection episode, 
positive microbiology was available for 80/90 
episodes, with growth from a deep bone sample in 46 
instances, blood culture in eleven, and a superficial 
wound swab alone in 26. Bacteraemia was due to S. 
aureus (4 MSSA, 1 MRSA), S. agalactiae (n=2), S. 
dysgalactiae (n=1), E. faecium (n=1) and Gram negative 
bacilli (GNB; n=3; Table S3). Deep bone samples were 
obtained intra-operatively in 43/46 episodes and by a 
Radiologist in 3 medically-managed episodes. In 
13/18 cases with sufficient data, antimicrobials were 
administered prior to surgery. Significant 
microbiology from deep bone samples is shown in 
Table S4. Infection was usually polymicrobial (40/46) 
and microbiologically heterogeneous, with S. aureus, 
Enterococci, GNB and anaerobes the most frequent 
pathogens. Gram positive bacteria were involved in 
43/46, Gram negative in 26/46 and anaerobes in 
16/46 (Figure S1). The sensitivity and specificity of 
superficial wound swabs for detection of S. aureus, 
Enterococci, GNB and anaerobes were calculated 
(Table 3), demonstrating inadequate performance 
when compared to deep bone samples from the same 
infection episode. In particular, the specificity of 
detection of S. aureus (36.4%) and GNB (43.8%) were 
particularly low. The sensitivity for detecting 
individual organisms from superficial swabs was also 
low: 47.4% for GNB, 50.0% for Enterococci, 55.6% for 
anaerobes and 76.5% for S. aureus. Overall, 45/91 
isolates (49.5%) from deep bone samples were 
detected on superficial swabs in episodes where both 
were obtained. 10/35 patients were colonised with 
MRSA and five developed MRSA infection. 
Sequential intra-operative bone samples were 
available for 12 patients (median 2 infection 
episodes/patient, range 2–4) encompassing a total of 
30 infection episodes a median of 84 days apart (IQR 
23–371). All were polymicrobial. Considering the 
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combined 101 isolates from these episodes, 44 (43.6%) 
were involved in subsequent infections. Considering 
individual patients, in 9/12 individuals at least one 
organism was involved in a further infection episode.  
Discussion 
Pressure ulcer-related pelvic osteomyelitis is a 
complex infection but remains relatively under- 
studied. In this retrospective cohort study of 35 
patients we sought to ask clinically relevant questions. 
This study is limited by its small sample size, 
single-centre design, retrospective nature and an 
inability to determine the clinical characteristics 
determining decisions to manage patients with or 
without surgery (including patient preference to 
undergo surgery). If a patient relocated to outwith the 
study region then instances of treatment failure could 
have been missed by the case ascertainment strategy. 
Host nutritional status 
Anaemia and hypo-albuminaemia were 
identified as risk factors for a non-healing ulcer and 
could relate to host nutritional status in the context of 
a catabolic state induced by chronic inflammation. 
Pre-operative anaemia is associated with an increased 
risk of post-operative infections in patients 
undergoing orthopaedic surgery [11-13], with the 
effect thought to be associated with an increased 
requirement for post-operative blood transfusion 
[12-15]. Thus, there is a risk-benefit balance between 
transfusion-related immune modulation and 
optimising oxygenation of the hypo-perfused wound. 
Measures such as nutritional optimisation and 
haematinic assessment should be prioritised to reduce 
reliance on blood transfusion. It has been suggested 
that blood transfusion should be avoided intra- 
operatively [16] and, if anticipated, should be 
administered at least 48 hours before surgery.  
Malnutrition is associated with multiple adverse 
outcomes following orthopaedic surgery: prolonged 
length of in-patient stay [17], delayed wound healing 
[18], surgical site infection (SSI) [19], sepsis [20], and 
death [20]. Serum albumin has been reported as a 
marker of nutritional status and hypo-albuminaemia 
(<35g L-1) has consistently been associated with 
increased risk of SSI following orthopaedic surgery 
[17, 20-23]. A recent international consensus meeting 
on orthopaedic infections strongly agreed that 
malnutrition was a modifiable risk factor for delayed 
wound healing [24] and SSI [25]. A possible 
alternative explanation for the observed association 
with hypo-albuminaemia and ulcer healing is loss of 
albumin via wound exudate, in a process similar to 
that occurring in burns patients [26]. 
 
Table 1. Characteristics of included patients with pressure 
ulcer-related pelvic osteomyelitis (n = 35) 
Characteristics N (%) 
Male (%) 26 (74) 
Age, mean (95% CI) years 57.4 (52.1–62.8) 
Neurological dysfunction 32 (91.4) 
Hemiplegia 2 (5.7) 
Paraplegia 27 (77.1) 
Quadriplegia 3 (8.6) 
Aetiology of neurologic dysfunction  
Trauma 10 (28.6) 
Multiple sclerosis 8 (22.9) 
Congential 7 (20.0) 
Othera 7 (20.0) 
Defunctioning colostomy 4 
Long-term urinary catheter 24 
Cierny-Mader host classification  
A 8 (22.9) 
B 26 (74.3) 
C 1 (2.9) 
Co-morbidities  
Diabetes mellitus 8 (22.9) 
Ischaemic heart disease or heart failure 6 (17.1) 
Chronic lung disease 4 (11.4) 
Otherb 4 (11.4) 
Site of pressure ulcer  
Ischium 19 
Sacrum 13 
Femur 3 
Site of osteomyelitis  
Ischium 18 (51.4) 
Proximal femur 5 (14.3) 
Sacro-coccygeal 5 (14.3) 
Sacrum 3 (8.6) 
Ischium and pubic ramus 2 (5.7) 
Ischium and proximal femur 1 (2.9) 
Coccyx 1 (2.9) 
Diagnostic parameters at index admission  
Total white cell count, x109 L-1 (mean, 95% CI) 12.7 (10.6–14.0) 
Neutrophil count, x109 L-1 (mean, 95% CI) 10.2 (8.3–12.2) 
C-reactive protein, mg L-1 (mean, 95% CI) 168 (132–205) 
Radiological findings (n=33)c  
Bone marrow oedema 25 (75.8) 
Bone cortex erosion 19 (57.6) 
Sequestra 5 (15.2) 
Myositis 20 (60.6) 
Collection or abscess 15 (45.5) 
Histopathological findings (n=9)  
Acute (neutrophilic) inflammation 1 (11.1) 
Chronic (monocytic) inflammation 4 (44.4) 
Acute and chronic inflammation 2 (22.2) 
Reactive changes only 2 (22.2) 
Significant microbiology from deep bone sample (n=25) 25 (100.0) 
Surgical intervention 24 (68.6) 
Debridement of tissue 2 (9.1)d 
Debridement of tissue and bone 20 (90.9)d 
Soft tissue coverage (direct primary closure or flap) 18 (81.8)d 
Outcomes  
Treatment failure 25 (71.4) 
Ulcer healinge 12 (36.4)e 
1-year mortalityf 8 (22.9) 
a encephalitis (n=3), subarachnoid haemorrhage (n=1), stroke (n=1), cauda equina 
syndrome (n=1), spinal cord infarct (n=1). b Other: chronic kidney disease (n=2); 
chronic liver disease (n=1); active malignancy (n=1). c radiology results available 
for 33/35 patients: 26 MRI, 7 CT.d data available for 22 patients.e at time of chart 
review, data available for 33 patients. f relative to date of index admission. 
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Table 2. Receiver operator characteristic analysis of risk factors associated with outcomes 
 Thresholda Sensitivity (%) Specificity (%) AUC Rating p-value AUC 95% CI 
Ulcer healing 
Age at index admission 59.5 years 70 75 0.75 Fair 0.019 0.57–0.93 
Diabetes mellitus NA   0.66 Poor 0.144 0.47–0.85 
Admission haemoglobin 111g L-1 100 75 0.81 Good 0.039 0.63–0.99 
Admission albumin 25g L-1 80 81 0.84 Good 0.026 0.66–1.00 
Soft tissue coverage after debridement NA   0.73 Fair 0.032 0.55–0.92 
Treatment failure 
No formal care support NA   0.72 Fair 0.045 0.53–0.91 
Post-traumatic neurological deficit NA   0.70 Fair 0.068 0.53–0.87 
Admission C-reactive protein 184mg L-1 63 80 0.78 Fair 0.013 0.60–0.95 
a Threshold for optimal diagnostic accuracy derived by calculation of the Youden J statistic. NA: not applicable (categorical variable); AUC: area under the curve 
 
Table 3. Sensitivity and specificity of superficial wound swabs 
compared to deep bone samples  
 Sensitivity (95% CI) Specificity (95% CI) 
Staphylococcus aureus 76.5 (50.1-93.2) 36.4 (10.9-69.2) 
Enterococci 50.0 (21.1-78.9) 86.7 (59.5-98.3) 
Gram negative bacilli 47.4 (24.5-71.1) 43.8 (19.8-70.1) 
Anaerobes 55.6 (21.2-86.3) 84.2 (60.4-96.6) 
 
Wound coverage 
Attempted soft tissue coverage was associated 
with eventual ulcer healing in this cohort. Two centres 
have reported good long-term outcomes using 
myo-cutaneous flaps. A flap was constructed in 
157/157 cases in one cohort (all pressure ulcers; 108 
with underlying osteomyelitis) and 30/61 in another 
(all pelvic osteomyelitis; 41 with pressure ulcers) [10, 
27]. In this latter cohort, 5/7 recurrences occurred in 
patients with osteomyelitis due to pressure ulcers. 
One retrospective study specifically sought risk 
factors for ulcer recurrence after debridement, 
reporting a hazard ratio of 0.8 for flap use, but with a 
wide 95% confidence interval of 0.2 to 3.1 [28]. 
However, flaps were only constructed in 25/70 
patients and underlying osteomyelitis was absent in 
18/70 lesions. Another centre reported flap 
construction after debridement in only 7/55 cases but 
no specific associated outcomes [29].  
Predicting and preventing treatment failure 
Treatment failure was predicted by admission 
CRP, lack of formal care support after discharge and a 
post-traumatic neurological deficit. CRP concentra-
tion at presentation has previously been found to 
independently predict treatment failure in 
musculoskeletal infections, possibly related to the 
burden of infection [30, 31].  
In the context of preventing treatment failure, a 
holistic perspective is warranted, considering patient 
concordance with treatment, wound care and 
pressure off-loading. Any underlying psychosocial 
factors that contributed to initial ulcer development 
should be identified and addressed, including formal 
care support after hospital discharge [10, 32]. Whilst 
Tissue Viability nursing input is the standard of care 
for patients in hospital, it is not known what wound 
care was delivered to patients in this cohort in the 
community after discharge. 
A multi-disciplinary team approach to musculo-
skeletal infection links clinicians (infection specialists, 
musculoskeletal radiologists, anaesthetists, plastic 
surgeons and orthopaedic surgeons) and allied health 
and care professionals (nurses, dieticians, physio-
therapists, occupational therapists, pharmacists, 
psychologists and social care co-ordinators) [33]. The 
cohort study from Dudareva and colleagues from the 
Oxford Bone Infection Unit reported a low recurrence 
rate (11%) in the setting of an established 
multi-disciplinary approach to pelvic osteomyelitis 
[10]. The definition of treatment failure used in this 
study did not include re-admission for intravenous 
antimicrobials which we did include, and not all 
patients had pressure ulcer-related osteomyelitis. 
Therefore, outcomes are not directly comparable 
between our cohort and theirs.  
Microbiological sampling and aetiology 
Based on the results of deep bone cultures we 
report a microbial aetiology comparable to other 
investigators [6, 7, 10, 29]. Importantly, we show 
superficial wound swabs are poor predictors of deep 
bone microbiology, thus are uninformative in 
determining aetiology of underlying osteomyelitis. 
One series reported that the implicated pathogen 
identified during recurrent episodes was unrelated to 
the index isolate in 86% of cases, and our data 
similarly show that only 43.6% of recovered organ-
isms were identified in subsequent infections [28]. 
Therefore, prior microbiology results do not reliably 
predict the aetiology of subsequent infection episodes 
and there is evidence for microbiological recurrence 
and de novo re-infection occurring simultaneously.  
Antimicrobial management 
We identified significant heterogeneity in the 
total duration of antimicrobial therapy during the 
index admission but no association with subsequent 
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treatment failure. To our knowledge this is the first 
report of this finding in a cohort of patients 
exclusively with pressure ulcer-related pelvic 
osteomyelitis, and supports similar findings by other 
investigators who have demonstrated that 
antimicrobial duration is not associated with healing 
of infected sacral pressure ulcers (with or without 
underlying osteomyelitis) [6, 34, 35]. The recent 
OVIVA trial included 6.8% patients with 
spinal/pelvic osteomyelitis but overall 322/376 
patients with chronic osteomyelitis (any site) had 
undergone debridement, therefore to extrapolate the 
trial findings to pressure ulcer-related pelvic 
osteomyelitis, further work will be required to define 
the sub-group of patients requiring surgical 
intervention [36]. The large cohort study from 
Bodavula and colleagues reports that combined 
medical and surgical management is associated with 
less re-admissions in the following year compared to 
antimicrobials alone [29]. Whilst this is an informative 
finding, the chronicity of this infection dictates that 
analysis of more than one year of follow-up will be 
required to reach definitive conclusions. Finally, the 
extent of osteomyelitis is likely to be a relevant factor 
when determining the length of antimicrobial therapy 
required, for example superficial cortical versus 
medullary involvement. There was insufficient 
histological information available to comment on this 
in our cohort. 
Anticipatory care planning 
In this series, 43% of patients had died after 
mean follow-up of 3.7 years. Other investigators have 
reported 20-25% mortality with mean follow-up of 
2.8–4.7 years [10, 37]. These findings speak to the 
importance of anticipatory care planning and 
‘Realistic Medicine’ following an index admission 
with pressure-ulcer related pelvic osteomyelitis [38]. 
Clinicians must continuously evaluate the 
appropriateness of aggressive management, entailing 
deep bone sampling, surgical debridement and 
embarking on lengthy and complex antimicrobial 
regimens. Such measures should not be pursued if 
and when a time arises when any benefits derived are 
outweighed by deleterious effects on the patient’s 
overall physiological, psychological and social 
wellbeing, viewed from the patient’s perspective. This 
is particularly pertinent when considering the high 
treatment failure rate resulting in re-admission and 
underscores the importance of preventing this. 
Realistic goals of care could include promoting 
healing of existing ulcers, preventing additional 
ulcers and treating acute flares of SSTI involving the 
ulcer with brief courses of antimicrobials. 
Conclusions 
Identification of the sub-group of patients who 
will benefit from surgery remains an important goal 
to advance the management of this disease. Formal 
personal care and nutrition are potentially modifiable 
factors associated with outcomes and should feature 
in strategies to optimise surgical outcomes. 
Admission CRP could be used to identify patients at 
risk of poor outcomes who may need closer follow- 
up. For patients undergoing surgical intervention, this 
should be performed as a combined ortho-plastic 
procedure to facilitate adequate debridement and 
early soft tissue reconstruction, when primary closure 
is not possible [10, 27]. Microbiological evaluation 
should involve deep bone sampling and not rely on 
superficial wound swabs. Antimicrobial duration is 
not associated with risk of treatment failure and 
shorter courses may be appropriate in some cases. The 
role of antimicrobials may be secondary to optimising 
the bio-psycho-social factors required for successful 
surgical intervention and subsequent wound healing. 
Almost one quarter of patients died within one-year 
of their index episode and therefore anticipatory care 
planning should be considered. A holistic approach to 
management is required, including dietetics, careful 
discharge planning, social care, tissue viability, 
infection specialists, plastic surgeons and orthopaedic 
surgeons. 
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